Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DRI-SATE DRY ACID CONCENTRATE FOR BICARBONATE DIALYSATE

K-Number: K022500 · 2002-12-23

ApplicantRockwell Medical Technologies, Inc.
Decision Date2002-12-23
Product CodeKPO
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

DRI-SATE DRY ACID CONCENTRATE FOR BICARBONATE DIALYSATE is the device name listed in this FDA 510(k) record. The listed applicant is Rockwell Medical Technologies, Inc.. It received FDA 510(k) clearance on 2002-12-23 under 510(k) number K022500. The device is classified under product code KPO. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DRI-SATE DRY ACID CONCENTRATE FOR BICARBONATE DIALYSATE?

DRI-SATE DRY ACID CONCENTRATE FOR BICARBONATE DIALYSATE is a medical device that received FDA 510(k) clearance on 2002-12-23. The listed applicant is Rockwell Medical Technologies, Inc.. The 510(k) number is K022500.

When did DRI-SATE DRY ACID CONCENTRATE FOR BICARBONATE DIALYSATE receive FDA 510(k) clearance?

DRI-SATE DRY ACID CONCENTRATE FOR BICARBONATE DIALYSATE received FDA 510(k) clearance on 2002-12-23, under 510(k) number K022500.

Who is the listed applicant for DRI-SATE DRY ACID CONCENTRATE FOR BICARBONATE DIALYSATE?

The FDA 510(k) record lists Rockwell Medical Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for DRI-SATE DRY ACID CONCENTRATE FOR BICARBONATE DIALYSATE?

The FDA product code for DRI-SATE DRY ACID CONCENTRATE FOR BICARBONATE DIALYSATE is KPO.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Rockwell Medical Technologies, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K062399ROCKWELL MEDICALTECHNOLOGIES, INC. CITRAPUREK023985ACIDIFIED COMPONENT CONCENTRATES FOR BICARBONATE DIALYSIS CONTAINING DI-ACETATEK022521BICARBONATE DIALYSATE CONCENTRATE MIXER, MODEL 50 GALLON & 100 GALLONK983618DRI-SATE MIXER FOR PREPARATION OF ACIDIFIED DIALYSATE CONCENTRATE

Related Devices (Code: KPO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260799Nipro Dry Acid Concentrate MixerNipro Technical Solutions, IncoporatedK253462NaturaLyte® Dry Bicarbonate Concentrate (08-4112-2)Fresenius Medical Care Renal Therapies Group, LLCK252180Bicarby Dialysate RFP-404 (RFP-404-W); Bicarby Dialysate RFP-403 (RFP-403-W); Bicarby Dialysate RFP-403 (RFP-403-G); Bicarby Dialysate RFP-453 (RFP-453-W); Bicarby Dialysate RFP-453 (RFP-453-G); Bicarby Dialysate RFP-454 (RFP-454-W); Bicarby Dialysate RFP-454 (RFP-454-G); Bicarby Dialysate RFP-456 (RFP-456-W)Fresenius Medical Care Renal Therapies Group, LLCK243786Bicarby Dialysate RFP-402 (RFP-402-G); Bicarby Dialysate RFP-400 (RFP-400-G); Bicarby Dialysate RFP-407 (RFP-407-G); Bicarby Dialysate RFP-401 (RFP-401-G); Bicarby Dialysate RFP-404 (RFP-404-G); Bicarby Dialysate RFP-456 (RFP-456-G); Ci-Ca Dialysate 2K (RFP-457-G); Ci-Ca Dialysate 4K (RFP-458-G)Fresenius Medical Care Renal Therapies Group, LLCK240920HemoCare Bicarbonate Concentrate Set (BCS)Deka Research and DevelopmentK233950pureFLOW 402 (F00012067); pureFLOW 406 (F00012068); pureFLOW 401 (F00012069); pureFLOW 400 (F00012070)Fresenius Medical Care Renal Therapies Group, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑